Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in specialty diagnostics, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
For more information, please visit www.bruker.com.
As part of the Nuclear Molecular Imaging Business Unit (NMI BU) within Bruker BioSpin’s PreClinical Imaging division (BBIO/PCI), our Ghent team of 17 colleagues is pushing the boundaries of preclinical research. We develop CUBES, benchtop preclinical SPECT/PET/CT imaging systems that enable researchers to conduct high‑quality studies without the complexity typically associated with advanced imaging equipment.
Joining our team in Ghent means becoming part of a dynamic and passionate group committed to giving scientists he tools they need to accelerate the development of new therapies. We are an experienced, driven team that strives to be best‑in‑class within the preclinical imaging segment.
Software Powered by iCIMS
www.icims.com